Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Amir Sherafat, Adeleh Sahebnasagh, Roya Rahmany, Farhad Mohammadi & Fatemeh Saghafi. (2022) The preventive effect of the combination of atorvastatin and nortriptyline in migraine-type headache: a randomized, triple-blind, placebo-controlled trial. Neurological Research 44:4, pages 311-317.
Read now
Read now
Chi-Un Pae. (2013) Comment on: The relationship between statins and depression: a review of the literature. Expert Opinion on Pharmacotherapy 14:17, pages 2449-2451.
Read now
Read now
Articles from other publishers (48)
Xianpeng Zu, Jiayun Xin, Haisheng Xie, Xike Xu, Yunheng Shen, Jinxin Wang, Saisai Tian, Yukun Wen, Hongxia Li, Jishun Yang & Yiqun Fang. (2024) Characteristics of gut microbiota and metabolic phenotype in patients with major depressive disorder based on multi-omics analysis. Journal of Affective Disorders 344, pages 563-576.
Crossref
Crossref
Francis M. HughesJr.Jr., Michael R. Odom, Anissa Cervantes, Austin J. Livingston & J. Todd Purves. (2023) Why Are Some People with Lower Urinary Tract Symptoms (LUTS) Depressed? New Evidence That Peripheral Inflammation in the Bladder Causes Central Inflammation and Mood Disorders. International Journal of Molecular Sciences 24:3, pages 2821.
Crossref
Crossref
Shuwen Wang, Tianhuan Lu, Jinyi Sun, Lihong Huang, Ruiqing Li, Tong Wang & Chuanhua Yu. (2023) Long-term trends in the incidence of depressive disorders in China, the United States, India and globally: A comparative study from 1990 to 2019. Frontiers in Psychology 13.
Crossref
Crossref
SaiSruthi Regalla, Gunampalli Anaika, BanaManishaa Reddy, PawanKumar Sharma & Enakshi Ganguly. (2022) Association of cognitive function, depression, and quality of sleep with statins among oldest-old individuals. Journal of the Indian Academy of Geriatrics 18:2, pages 78.
Crossref
Crossref
Shu-Hui TaoXue-Qun RenLi-Jun Zhang & Mei-Yan Liu. (2021) Association between common cardiovascular drugs and depression. Chinese Medical Journal 134:22, pages 2656-2665.
Crossref
Crossref
Hon-Cheong So, Carlos Kwan-long Chau, Yu-ying Cheng & Pak C. Sham. (2020) Causal relationships between blood lipids and depression phenotypes: a Mendelian randomisation analysis. Psychological Medicine 51:14, pages 2357-2369.
Crossref
Crossref
Dana Končelíková. (2021) Drug-induced depression. Neurologie pro praxi 22:4, pages 303-307.
Crossref
Crossref
Jun He, Feiyun Ouyang, Ling Li, Dan Qiu, Yilu Li & Shuiyuan Xiao. (2021) Incidence trends of major depressive disorder in China: an age-period-cohort modeling study. Journal of Affective Disorders 288, pages 10-16.
Crossref
Crossref
Yanbo Li, Yijia Guo, Muke Zhou, Mengmeng Ma, Jinghuan Fang & Li He. (2021) Paradoxical effect of statin medication on depressive disorder in first-ever ischemic stroke patients: possible antidepressant-like effect prestroke and the opposite in continuous medication poststroke. International Clinical Psychopharmacology 36:3, pages 147-153.
Crossref
Crossref
Micaela Gliozzi, Vincenzo Musolino, Francesca Bosco, Miriam Scicchitano, Federica Scarano, Saverio Nucera, Maria Caterina Zito, Stefano Ruga, Cristina Carresi, Roberta Macrì, Lorenza Guarnieri, Jessica Maiuolo, Annamaria Tavernese, Anna Rita Coppoletta, Caterina Nicita, Rocco Mollace, Ernesto Palma, Carolina Muscoli, Catherine Belzung & Vincenzo Mollace. (2021) Cholesterol homeostasis: Researching a dialogue between the brain and peripheral tissues. Pharmacological Research 163, pages 105215.
Crossref
Crossref
Yasmina Molero, Andrea Cipriani, Henrik Larsson, Paul Lichtenstein, Brian M D'Onofrio & Seena Fazel. (2020) Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study. The Lancet Psychiatry 7:11, pages 982-990.
Crossref
Crossref
A G Zhidyaevskj, V D Mendelevich, G S Galyautdinov, K R Ibragimova & E B Zakirova. (2020) Features of mental disorders and their correction in patients with cardiac pathology. Kazan medical journal 101:2, pages 212-225.
Crossref
Crossref
Mojtaba Dolatshahi, Saeed Davoudi, Yousef Paridar, Reza Naserzadeh & Behnam Ghorbanzadeh. (2020) Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of simvastatin in mice: Without tolerance and withdrawal syndrome. Neuroscience Letters 714, pages 134578.
Crossref
Crossref
Hon-Cheong So, Carlos Kwan-Long Chau, Alexandria Lau, Sze-Yung Wong & Kai Zhao. (2018) Translating GWAS findings into therapies for depression and anxiety disorders: gene-set analyses reveal enrichment of psychiatric drug classes and implications for drug repositioning. Psychological Medicine 49:16, pages 2692-2708.
Crossref
Crossref
Laura Schang, Daniela Koller, Sebastian Franke & L Sundmacher. (2019) Exploring the role of hospitals and office-based physicians in timely provision of statins following acute myocardial infarction: a secondary analysis of a nationwide cohort using cross-classified multilevel models. BMJ Open 9:10, pages e030272.
Crossref
Crossref
Shih-Chieh Chien, Po-Sheng Chen, Yi-Hsiang Huang, Sung-Chun Tang, Yi-Heng Li & Hung-I Yeh. (2019) 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance. Journal of the Formosan Medical Association 118:10, pages 1385-1392.
Crossref
Crossref
Bruno Agustini, Mohammadreza Mohebbi, Robyn L. Woods, John J. McNeil, Mark R. Nelson, Raj C. Shah, Anne M. Murray, Michael E. Ernst, Christopher M. Reid, Andrew Tonkin, Jessica E. Lockery & Michael Berk. (2019) Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study. CNS Drugs 33:7, pages 685-694.
Crossref
Crossref
Angelos Halaris & Brian E. Leonard. (2019) Unraveling the complex interplay of immunometabolic systems that contribute to the neuroprogression of psychiatric disorders. Neurology, Psychiatry and Brain Research 32, pages 111-121.
Crossref
Crossref
Kai Zhao & Hon-Cheong So. (2019) Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data. IEEE Journal of Biomedical and Health Informatics 23:3, pages 1304-1315.
Crossref
Crossref
Reza Naserzadeh, Niloofar Abad, Behnam Ghorbanzadeh, Mojtaba Dolatshahi & Mohammad Taghi Mansouri. (2019) Simvastatin exerts antidepressant-like activity in mouse forced swimming test: Role of NO-cGMP-KATP channels pathway and PPAR-gamma receptors. Pharmacology Biochemistry and Behavior 180, pages 92-100.
Crossref
Crossref
Brian Chi‐Fung Wong, Carlos Kwan‐Long Chau, Fu‐Kiu Ao, Cheuk‐Hei Mo, Sze‐Yung Wong, Yui‐Hang Wong & Hon‐Cheong So. (2018) Differential associations of depression‐related phenotypes with cardiometabolic risks: Polygenic analyses and exploring shared genetic variants and pathways. Depression and Anxiety 36:4, pages 330-344.
Crossref
Crossref
Jahad Alghamdi, Sabine Matou-Nasri, Faisal Alghamdi, Saleh Alghamdi, Majid Alfadhel & Sandosh Padmanabhan. (2018) Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study. International Journal of Neuropsychopharmacology 21:12, pages 1067-1075.
Crossref
Crossref
Alfonso Troisi & Roberta Croce Nanni. (2018) Normal cholesterol levels in the immediate postpartum period: A risk factor for depressive and anxiety symptoms?. Psychiatry Research 269, pages 394-398.
Crossref
Crossref
Handrean Soran, Jan Hoong Ho & Paul N. Durrington. (2018) Acquired low cholesterol. Current Opinion in Lipidology 29:4, pages 318-326.
Crossref
Crossref
Eun Young Kim, Jae Won Lee, Min Young Lee, Se Hyun Kim, Hyuck Jun Mok, Kyooseob Ha, Yong Min Ahn & Kwang Pyo Kim. (2018) Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients. Psychiatry Research 265, pages 174-182.
Crossref
Crossref
. (2017) Cognitive Function in a Randomized Trial of Evolocumab. New England Journal of Medicine 377:20, pages 1996-1997.
Crossref
Crossref
Željka Korade, Wei Liu, Emily B. Warren, Kristan Armstrong, Ned A. Porter & Christine Konradi. (2017) Effect of psychotropic drug treatment on sterol metabolism. Schizophrenia Research 187, pages 74-81.
Crossref
Crossref
Ole Köhler-Forsberg, Christiane Gasse, Michael Berk & Søren Dinesen Østergaard. (2017) Do Statins Have Antidepressant Effects?. CNS Drugs 31:5, pages 335-343.
Crossref
Crossref
Mohammad Mahdi Ahmadian-Attari, Ahmad Ali Noorbala, Alireza Khoshdel, Mohammad Kamalinejad & Arsia Taghva. (2016) Omega-3 Fatty Acids and Cholesterol Have a Main Role in Antidepression Diet of Iranian Traditional Medicine. Journal of Evidence-Based Complementary & Alternative Medicine 22:2, pages 205-209.
Crossref
Crossref
A. Robles Bayón & F. Gude Sampedro. (2017) Behavioural and psychiatric symptoms in cognitive neurology. Neurología (English Edition) 32:2, pages 81-91.
Crossref
Crossref
A. Robles Bayón & F. Gude Sampedro. (2017) Síntomas conductuales y psiquiátricos en neurología cognitiva. Neurología 32:2, pages 81-91.
Crossref
Crossref
K L Ong, M J Morris, R L McClelland, J Maniam, M A Allison & K-A Rye. (2016) Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis. Translational Psychiatry 6:11, pages e962-e962.
Crossref
Crossref
Estela Salagre, Brisa S. Fernandes, Seetal Dodd, Daniel J. Brownstein & Michael Berk. (2016) Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials. Journal of Affective Disorders 200, pages 235-242.
Crossref
Crossref
Michael Hawkins, Ayal Schaffer, Catherine Reis, Mark Sinyor, Nathan Herrmann & Krista L. Lanctôt. (2016) Suicide in males and females with cardiovascular disease and comorbid depression. Journal of Affective Disorders 197, pages 88-93.
Crossref
Crossref
Paul D. Thompson, Gregory Panza, Amanda Zaleski & Beth Taylor. (2016) Statin-Associated Side Effects. Journal of the American College of Cardiology 67:20, pages 2395-2410.
Crossref
Crossref
MARIOLA HERBET, MONIKA GAWROŃSKA-GRZYWACZ, MAGDALENA IZDEBSKA, IWONA PIĄTKOWSKA-CHMIEL & EWA JAGIEŁŁO-WÓJTOWICZ. (2016) Impact of combined treatment with rosuvastatin and antidepressants on liver and kidney function in rats. Experimental and Therapeutic Medicine 11:4, pages 1459-1464.
Crossref
Crossref
Yu Zhang, Lin Cheng, Yajing Chen, Guo-Yuan Yang, Jianrong Liu & Lili Zeng. (2016) Clinical predictor and circulating microRNA profile expression in patients with early onset post-stroke depression. Journal of Affective Disorders 193, pages 51-58.
Crossref
Crossref
Ole Köhler & Christiane Gasse. 2016. Cardiovascular Diseases and Depression. Cardiovascular Diseases and Depression
445
465
.
Raymond Noordam, Nikkie Aarts, Catherine E de Keyser, Albert Hofman, Bruno H Stricker & Loes E Visser. (2015) Antidepressants with a high serotonin reuptake transporter affinity and serum lipid levels in a population-based study in older adults. Journal of Psychopharmacology 29:10, pages 1112-1118.
Crossref
Crossref
Reema D. Mehta & Andrew J. Roth. (2015) Psychiatric considerations in the oncology setting. CA: A Cancer Journal for Clinicians 65:4, pages 299-314.
Crossref
Crossref
Jiunn-Horng Kang, Li-Ting Kao, Herng-Ching Lin, Ming-Chieh Tsai & Shiu-Dong Chung. (2015) Statin use increases the risk of depressive disorder in stroke patients: A population-based study. Journal of the Neurological Sciences 348:1-2, pages 89-93.
Crossref
Crossref
Arash Shahsavarian, Shiva Javadi, Samane Jahanabadi, Mina Khoshnoodi, Javad Shamsaee, Hamed Shafaroodi, Shahram Ejtemaei Mehr & Ahmadreza Dehpour. (2014) Antidepressant-like effect of atorvastatin in the forced swimming test in mice: The role of PPAR-gamma receptor and nitric oxide pathway. European Journal of Pharmacology 745, pages 52-58.
Crossref
Crossref
Kristopher J. Swiger, Raoul J. Manalac, Michael J. Blaha, Roger S. Blumenthal & Seth S. Martin. (2014) Statins, mood, sleep, and physical function: a systematic review. European Journal of Clinical Pharmacology 70:12, pages 1413-1422.
Crossref
Crossref
Babajohn Ainiyet & Janusz K. Rybakowski. (2014) Suicidal behaviour and lipid levels in unipolar and bipolar depression. Acta Neuropsychiatrica 26:5, pages 315-320.
Crossref
Crossref
Anna Maria Malfitano, Giuseppe Marasco, Maria Chiara Proto, Chiara Laezza, Patrizia Gazzerro & Maurizio Bifulco. (2014) Statins in neurological disorders: An overview and update. Pharmacological Research 88, pages 74-83.
Crossref
Crossref
Rita Citraro, Serafina Chimirri, Rossana Aiello, Luca Gallelli, Francesca Trimboli, Domenico Britti, Giovambattista De Sarro & Emilio Russo. (2014)
Protective effects of some statins on epileptogenesis and depressive‐like behavior in
WAG
/Rij rats, a genetic animal model of absence epilepsy
. Epilepsia 55:8, pages 1284-1291.
Crossref
Crossref
Zobair M. Younossi, Maria Stepanova, Linda Henry, Edward Gane, Ira M. Jacobson, Eric Lawitz, David Nelson, Lynn Gerber, Fatema Nader & Sharon Hunt. (2014) Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology 12:8, pages 1349-1359.e13.
Crossref
Crossref
Marco Tuccori, Sabrina Montagnani, Stefania Mantarro, Alice Capogrosso-Sansone, Elisa Ruggiero, Alessandra Saporiti, Luca Antonioli, Matteo Fornai & Corrado Blandizzi. (2014) Neuropsychiatric Adverse Events Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management. CNS Drugs 28:3, pages 249-272.
Crossref
Crossref